Pancreatic Cancer Research

ResearcherTongji UniversityNo recent work listed

Bingyan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-4207-2947; OpenAlex author ID A5104272576. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Hsa_circ_0014784-induced YAP1 promoted the progression of pancreatic cancer by sponging miR-214-3p. Co-author DOI 10.1080/15384101.2023.2222519↗
  2. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. Co-author DOI 10.1111/jcmm.14896↗
  3. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer. Co-author DOI 10.1016/j.omtn.2018.09.026↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aiwu Mao · 2 shared papers, 2018–2020 · strength 0.19
  2. Mingyi Shang · 2 shared papers, 2018–2020 · strength 0.19
  3. Dengke Yang · 1 shared paper, 2023 · strength 0.18
  4. Quanjun Lin · 1 shared paper, 2023 · strength 0.18
  5. Jun Ma · 1 shared paper, 2020 · strength 0.11
  6. Zhongmin Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.